查找临床试验
已按「特发性肺纤维化」检索，对应国际通用词 idiopathic pulmonary fibrosis
共找到 10 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 10:07，每 5 分钟自动同步Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
United States、Australia、Bulgaria、Canada、France 等 12 国
年龄 40 Years – 不限
AbbVie
A Adaptive Design Clinical Trial to Evaluate the Efficacy and Safety of TDI01 Suspension in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
China
年龄 40 Years – 80 Years
Beijing Tide Pharmaceutical Co., Ltd
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
United States、Argentina、Australia、Bulgaria、Canada 等 12 国
年龄 40 Years – 不限
AstraZeneca
A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of SV001 in Chinese Healthy Adult Volunteers.
China
年龄 18 Years – 45 Years
Shanghai Synvida Biotechnology Co.,Ltd.
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of SV001 in Patients With Idiopathic Pulmonary Fibrosis
China
年龄 40 Years – 不限
Shanghai Synvida Biotechnology Co.,Ltd.
SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)
China
年龄 40 Years – 80 Years
Guangzhou JOYO Pharma Co., Ltd
Inspiratory Flow Rate Capability in Pulmonary Fibrosis Patients
China
年龄 18 Years – 80 Years
Shanghai Pulmonary Hospital, Shanghai, China
Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF
China
年龄 40 Years – 80 Years
Sunshine Lake Pharma Co., Ltd.
Phase II Clinical Study of BC006 in Patients With Idiopathic Pulmonary Fibrosis
China
年龄 40 Years – 不限
Dragonboat Biopharmaceutical Company Limited
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
United States、Argentina、Australia、Austria、Belgium 等 12 国
年龄 18 Years – 不限
Boehringer Ingelheim